Grand Brilliance Group Holdings Limited (HKG:8372)
Hong Kong · Delayed Price · Currency is HKD 0.1330
+0.0010 (0.76%)
Jul 20, 2026, 6:11 PM HKT
HKG:8372 Market Cap
HKG:8372 has a market cap or net worth of 106.4 million as of July 21, 2026. Its market cap has increased by 16.67% in one year.
Market Cap
106.40M
Enterprise Value
51.40M
Revenue
100.71M
Ranking
n/a
PE Ratio
12.65
Stock Price
0.13
ChartMarket Cap Chart
Since March 29, 2018, HKG:8372's market cap has decreased from 320.00M to 106.40M, a decrease of -66.75%. That is a compound annual growth rate of -12.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 106.40M | 1.53% |
| Dec 31, 2025 | 104.80M | 47.19% |
| Dec 31, 2024 | 71.20M | -11.00% |
| Dec 29, 2023 | 80.00M | 33.33% |
| Dec 30, 2022 | 60.00M | 10.29% |
| Dec 31, 2021 | 54.40M | -9.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinopharm Group | 54.83B |
| 160 Health International | 3.15B |
| Sipai Health Technology | 1.08B |
| ETHK Labs | 1.01B |
| Charmacy Pharmaceutical | 788.40M |
| China Health Group | 527.11M |
| ClouDr Group | 342.23M |
| Sinco Pharmaceuticals Holdings | 341.53M |